Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
16-Jul-2019
Appendix 3Y - Johnston
16-Jul-2019
Appendix 3Y - Irminger-Finger
16-Jul-2019
Appendix 3Y - Gunzburg
12-Jul-2019
Completion of Capital Raising Package
12-Jul-2019
Appendix 3B and Cleansing Notice 708A
10-Jul-2019
Closure of Entitlement Offer and Shortfall Notification
1-Jul-2019
Progress on Assay Development Program
26-Jun-2019
Despatch of Offer Document
19-Jun-2019
603 SSN - Merchant Funds Management Pty Ltd
19-Jun-2019
603 SSN - Jeffrey Emmanuel
Previous
1
2
3
4
5
Next
